Citations (43)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (8)
Hanna Prucha, Christina Schnopp, Cezmi Akdis, Roger Lauener, Andreas Wollenberg, Johannes Ring & Claudia Traidl-Hoffmann. (2013)
Pimecrolimus, a topical calcineurin inhibitor used in the treatment of atopic eczema. Expert Opinion on Drug Metabolism & Toxicology 9:11, pages 1507-1516.
Read now
Read now
Jean Ayer & Helen S Young. (2013)
Pimecrolimus for psoriasis. Expert Opinion on Pharmacotherapy 14:6, pages 767-774.
Read now
Read now
Christos E Lampropoulos & David P D’Cruz. (2010) Topical calcineurin inhibitors in systemic lupus erythematosus. Therapeutics and Clinical Risk Management 6, pages 95-101.
Read now
Read now
Kristine L Busse, Ali Alikhan & Steven R Feldman. (2009) Optimizing topical therapy for psoriasis. Expert Review of Dermatology 4:4, pages 385-402.
Read now
Read now
Chrysovalantis Korfitis, Stamatis Gregoriou, Efstathios Rallis & Dimitris Rigopoulos. (2007) Pimecrolimus versus topical corticosteroids in dermatology. Expert Opinion on Pharmacotherapy 8:10, pages 1565-1573.
Read now
Read now
Uwe Wollina, Gesina Hansel, André Koch & Mohamed Badawy Abdel-Naser. (2006) Topical pimecrolimus for skin disease other than atopic dermatitis. Expert Opinion on Pharmacotherapy 7:14, pages 1967-1975.
Read now
Read now
Simon Skurkovich, Boris Skurkovich & Jeanne Kelly. (2005) Anticytokine therapy, particularly anti-IFN-γ, in Th1-mediated autoimmune diseases. Expert Review of Clinical Immunology 1:1, pages 11-25.
Read now
Read now
Melissa A Magliocco. (2005) Emerging drugs for moderate-to-severe psoriasis. Expert Opinion on Emerging Drugs 10:1, pages 35-52.
Read now
Read now
Articles from other publishers (35)
Julie Quartier, Maria Lapteva, Younes Boulaguiem, Stéphane Guerrier & Yogeshvar N. Kalia. (2023) Influence of Molecular Structure and Physicochemical Properties of Immunosuppressive Drugs on Micelle Formulation Characteristics and Cutaneous Delivery. Pharmaceutics 15:4, pages 1278.
Crossref
Crossref
Ludger A. Wessjohann, Richard Bartelt & Wolfgang Brandt. 2017. Practical Medicinal Chemistry with Macrocycles. Practical Medicinal Chemistry with Macrocycles
77
100
.
In-Seung Lee, Hyun Jin Ahn, Kang-Hoon Kim, Jiyoung Park, Yumi Kim, Jin Woo Han, Dong Hyun Kim, Ji Hoon Jung, Hee Jae Jung & Hyeung-Jin Jang. (2016) The effects of Baekho-tang on 1-Fluoro-2, 4-dinitrofluorobenzene-induced allergic contact dermatitis in BALB/c mice. Oriental Pharmacy and Experimental Medicine 16:4, pages 349-354.
Crossref
Crossref
Ge Qian, Tao Liu, Chongchen Zhou & Yinghui Zhang. (2015) Successful treatment of recalcitrant granulomatous rosacea with oral thalidomide and topical pimecrolimus. The Journal of Dermatology 42:5, pages 539-540.
Crossref
Crossref
Michele D. Mignogna, Annamaria Pollio, Stefania Leuci, Elvira Ruoppo & Giulio Fortuna. (2013) Clinical behaviour and long‐term therapeutic response in orofacial granulomatosis patients treated with intralesional triamcinolone acetonide injections alone or in combination with topical pimecrolimus 1%. Journal of Oral Pathology & Medicine 42:1, pages 73-81.
Crossref
Crossref
S.H. Jung, X. Sun, W.-S. Ryu & B.-S. Yang. (2013) Topical administration of the pan-Src kinase inhibitors, dasatinib and LCB 03-0110, prevents allergic contact dermatitis in mice. British Journal of Dermatology 168:1, pages 112-119.
Crossref
Crossref
Steven R FeldmanKristine B ZitelliAli Alikhan. 2011. Current and Emerging Treatments for Psoriasis. Current and Emerging Treatments for Psoriasis
32
59
.
Murty A. R. C. Bulusu, Karl Baumann & Anton Stuetz. 2011. Progress in the Chemistry of Organic Natural Products Vol. 94. Progress in the Chemistry of Organic Natural Products Vol. 94
59
126
.
Meng Xianjiang & Wang Junjie. 2011. Electrical Power Systems and Computers. Electrical Power Systems and Computers
691
696
.
Xiao-Ying Yuan, Wei Liu, Ping Zhang, Rui-Yan Wang & Jian-You Guo. (2010) Effects and mechanisms of aloperine on 2, 4-dinitrofluorobenzene-induced allergic contact dermatitis in BALB/c mice. European Journal of Pharmacology 629:1-3, pages 147-152.
Crossref
Crossref
Simone Meindl, Christine Vaculik, Josef G. Meingassner, Gero Kramer, Johnnie Akgün, Marion Prior, Anton Stuetz, Georg Stingl & Adelheid Elbe-Bürger. (2009) Differential Effects of Corticosteroids and Pimecrolimus on the Developing Skin Immune System in Humans and Mice. Journal of Investigative Dermatology 129:9, pages 2184-2192.
Crossref
Crossref
Hyoseung SHIN, Oh Sang KWON, Chong Hyun WON, Beom Joon KIM, Yang Won LEE, Yong Beom CHOE, Kyu Joong AHN & Hee Chul EUN. (2009) Clinical efficacies of topical agents for the treatment of seborrheic dermatitis of the scalp: A comparative study. The Journal of Dermatology 36:3, pages 131-137.
Crossref
Crossref
Ron Ofri, George N. Lambrou, Ingrid Allgoewer, Uwe Graenitz, Teresa M. Pena, Bernhard M. Spiess & Elisabeth Latour. (2009) Clinical evaluation of pimecrolimus eye drops for treatment of canine keratoconjunctivitis sicca: A comparison with cyclosporine A. The Veterinary Journal 179:1, pages 70-77.
Crossref
Crossref
Gionata Buggiani, Federica Ricceri & Torello Lotti. (2008) Atopic dermatitis. Dermatologic Therapy 21:2, pages 96-100.
Crossref
Crossref
Hans-Peter Gschwind, Felix Waldmeier, Markus Zollinger, Alain Schweitzer & Maximilian Grassberger. (2008) Pimecrolimus: Skin disposition after topical administration in minipigs in vivo and in human skin in vitro. European Journal of Pharmaceutical Sciences 33:1, pages 9-19.
Crossref
Crossref
Antonio E. Muñiz. 2008. Pediatric Emergency Medicine. Pediatric Emergency Medicine
859
870
.
U Wollina & G Hansel. (2007) The use of topical calcineurin inhibitors in lupus erythematosus: an overview. Journal of the European Academy of Dermatology and Venereology 0:0, pages 071115111654005-???.
Crossref
Crossref
T Oppel, T Pavicic, S Kamann, M Bräutigam & A Wollenberg. (2007) Pimecrolimus cream (1%) efficacy in perioral dermatitis ? results of a randomized, double-blind, vehicle-controlled study in 40 patients. Journal of the European Academy of Dermatology and Venereology 0:0, pages 070525001847013-???.
Crossref
Crossref
AP de Moraes, ÉÂG de Arruda, MAV Vitoriano, MO de Moraes Filho, FÂF Bezerra, E de Magalhães Holanda & MEA de Moraes. (2007) An open-label efficacy pilot study with pimecrolimus cream 1% in adults with facial seborrhoeic dermatitis infected with HIV. Journal of the European Academy of Dermatology and Venereology 0:0, pages 070322060316001-???.
Crossref
Crossref
Uwe Wollina. (2007) The Role of Topical Calcineurin Inhibitors for Skin Diseases Other Than Atopic Dermatitis. American Journal of Clinical Dermatology 8:3, pages 157-173.
Crossref
Crossref
Markus Dawid, Marge Veensalu, Maximilian Grassberger & Klaus Wolff. (2006) Efficacy and safety of pimecrolimus cream 1% in adult patients with vitiligo: Results of a randomized, double-blind, vehicle-controlled study. JDDG 4:11, pages 942-946.
Crossref
Crossref
Jann L??bbe, Sheila F Friedlander, Bernard Cribier, Marie-Anne Morren, Amaro Garc??a-D??ez, Carlo Gelmetti, Heidelore Hofmann, Ronald H Houwing, Stephen Kownacki, Richard G B Langley, Marie Virtanen, Klaus Wolff, Steve Wisseh, Claire McGeown, Beatrice Abrams & Dirk Schneider. (2006) Safety, Efficacy, and Dosage of 1% Pimecrolimus Cream for the Treatment of Atopic Dermatitis in Daily Practice. American Journal of Clinical Dermatology 7:2, pages 121-131.
Crossref
Crossref
Robert P Numerof & Khusru Asadullah. (2006) Cytokine and Anti-Cytokine Therapies for Psoriasis and Atopic Dermatitis. BioDrugs 20:2, pages 93-103.
Crossref
Crossref
Carle Paul, Michael Cork, Ana B. Rossi, Kim A. Papp, Nathalie Barbier & Yves de Prost. (2006) Safety and Tolerability of 1% Pimecrolimus Cream Among Infants: Experience With 1133 Patients Treated for Up to 2 Years. Pediatrics 117:1, pages e118-e128.
Crossref
Crossref
Dagmar Simon, Jann Lübbe, Brunello Wüthrich, Alice Wiesner, M. Monika Weber, Emmanuel Laffitte, Mark D. Anliker, Martin H. Schöni, Lasse R. Braathen, Peter Schmid-Grendelmeier, Nicole Gilgen Bobalj & Dirk Schneider. (2006) Benefits from the Use of a Pimecrolimus-Based Treatment in the Management of Atopic Dermatitis in Clinical Practice. Dermatology 213:4, pages 313-318.
Crossref
Crossref
U. Mrowietz. 2006. Pädiatrische Dermatologie. Pädiatrische Dermatologie
391
401
.
J. Joachim, N. François, P. Piccerelle, J. Kister, J.-P. Reynier, P. Humbert & F. Aubin. (2005) Mécanismes et traitements du psoriasis. La Presse Médicale 34:22, pages 1727-1736.
Crossref
Crossref
E. Enderlein, S. Meller, J. Rieker, T. Ruzicka & B. Homey. (2005) Aktuelle Aspekte der Therapie mit topischen CalcineurininhibitorenCurrent aspects of the therapy with topical calcineurin inhibtors. Der Hautarzt 56:10, pages 937-941.
Crossref
Crossref
K. Wolff, C. Fleming, J. Hanifin, K. Papp, S. Reitamo, M. Rustin, N. Shear, W. Silny, N. Korman, I. Marks, R. Cherill, S. Emady-Azar & C. Paul. (2005) Efficacy and tolerability of three different doses of oral pimecrolimus in the treatment of moderate to severe atopic dermatitis: a randomized controlled trial. British Journal of Dermatology 152:6, pages 1296-1303.
Crossref
Crossref
A. M. Marsland, S. Soundararajan, K. Joseph & A. P. Kaplan. (2005) Effects of calcineurin inhibitors on an in vitro assay for chronic urticaria. Clinical <html_ent glyph="@amp;" ascii="&"/> Experimental Allergy 35:5, pages 554-559.
Crossref
Crossref
Karl Baumann, Klemens Hoegenauer, Hermann Knapp, Markus Bacher, Andrea Steck & Trixie Wagner. (2005) On the reactivity of ascomycin at the binding domain. Part 3: Reactivity of the binding domain towards diazomethane. Tetrahedron 61:20, pages 4819-4829.
Crossref
Crossref
Andreas Billich, Hermann Vyplel, Maximilian Grassberger, Fritz P. Schmook, Andrea Steck & Anton Stuetz. (2005) Novel cyclosporin derivatives featuring enhanced skin penetration despite increased molecular weight. Bioorganic & Medicinal Chemistry 13:9, pages 3157-3167.
Crossref
Crossref
B. Skurkovich & S. Skurkovich. 2005. Cytokines as Potential Therapeutic Targets for Inflammatory Skin Diseases. Cytokines as Potential Therapeutic Targets for Inflammatory Skin Diseases
1
27
.
Thomas A. Luger. 2005. Fortschritte der praktischen Dermatologie und Venerologie. Fortschritte der praktischen Dermatologie und Venerologie
527
530
.
Murty A.R.C Bulusu, Peter Waldstätten, Thomas Tricotet, Christophe Rochais, Andrea Steck & Markus Bacher. (2004) Synthesis of 6-vinyl and 5-vinylproline analogues of ascomycin. Tetrahedron Letters 45:30, pages 5833-5836.
Crossref
Crossref